» Articles » PMID: 33463382

A Narrative Review of Predictors for β-lactam Antibiotic Exposure During Empirical Treatment in Critically Ill Patients

Overview
Publisher Informa Healthcare
Date 2021 Jan 19
PMID 33463382
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: : Emerging studies suggest that antibiotic pharmacokinetics (PK) are difficult to predict in critically ill patients. The high intra- and inter-patient PK variability makes it challenging to accurately predict the appropriate dosage required for a given patient. Identifying patients at risk could help clinicians to consider more individualized dosing regimens and perform therapeutic drug monitoring. We provide an overview of relevant predictors associated with target (non-)attainment of β-lactam antibiotics in critically ill patients.

Areas Covered: : This narrative review summarizes patient and clinical characteristics that can help to predict the attainment of target serum concentrations and to provide guidance on antimicrobial dose optimization. Literature was searched using Embase and Medline database, focusing on β-lactam antibiotics in critically ill patients.

Expert Opinion: : Adequate concentration attainment can be anticipated in critically ill patients prior to initiating empiric β-lactam antibiotic therapy based on readily available demographic and clinical factors. Male gender, younger age, and augmented renal clearance were the most significant predictors for target non-attainment and should be considered in further investigations to develop dosing algorithms for optimal β-lactam therapy.

Citing Articles

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients.

Wang J, Fang Q, Luo X, Jin L, Zhu H Front Pharmacol. 2025; 15:1524272.

PMID: 39850576 PMC: 11754279. DOI: 10.3389/fphar.2024.1524272.


Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review.

Gatti M, Pea F Front Antibiot. 2025; 3():1426753.

PMID: 39816245 PMC: 11732092. DOI: 10.3389/frabi.2024.1426753.


Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis.

Gatti M, Cojutti P, Pea F Crit Care. 2024; 28(1):123.

PMID: 38627763 PMC: 11020314. DOI: 10.1186/s13054-024-04911-5.


Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models.

Wieringa A, Ewoldt T, Gangapersad R, Gijsen M, Parolya N, Kats C Antibiotics (Basel). 2023; 12(12).

PMID: 38136709 PMC: 10740552. DOI: 10.3390/antibiotics12121674.


-Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study.

Guilhaumou R, Chevrier C, Setti J, Jouve E, Marsot A, Julian N Antibiotics (Basel). 2023; 12(8).

PMID: 37627709 PMC: 10451857. DOI: 10.3390/antibiotics12081289.